1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 09 MARCH 2015

Cancer Drug News 09 MARCH 2015

  • March 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Novartis Will Maximise GSK Oncology Revenues
Industry Brief - Eisai/Merck Collaborate To Explore Keytruda, Lenvima And Halaven Combination Regimens
Industry Trend Analysis - Spectrum Bolsters Pipeline With Poziotinib Agreement
Industry Brief - Radius Acquires Japanese Rights To RAD1901; Appoints SVP/Head Of Global Oncology
Industry Brief - BioLineRx Files Application To Initiate BL-8040 Phase IIb Trial In AML
Industry Brief - Incyte Sponsors First US Observational Study For PV
Industry Brief - AOP Orphan Completes Enrolment In Phase III Trial Of Ropeginterferon Alfa 2b For PV
Industry Brief - Pacritinib Phase III Trial Meets Primary Endpoint In MF
Industry Brief - FDA Accepts Spectrum's NDA Filing For Captisol-Enabled Melphalan
Industry Trend Analysis - Anti-PD1 Race Continues Despite BMS' NSCLC Approval Win
Industry Brief - Combination Cell-Gene Therapy For LC To Be Tested In UK Patients
Industry Brief - ACD's RNAscope Technology Supports Merrimack's MM-121 Phase II Trial
Industry Trend Analysis - BMS Highlights Potential Of Cancer Vaccines With Bavarian Nordic Deal
Industry Brief - CHMP Issues Positive Opinion For Avastin Plus CT In Advanced CC
Industry Brief - FDA Grants ODD To Oncolytics' Reolysin For Fallopian Tube Cancer
Industry Brief - ORYX Completes Phase I/IIa Trial Of VicOryx In HPV-Positive Cancers
Industry Brief - Bayer Halts Enrolment In Regorafenib Phase III Trial For CRC
Industry Brief - Tivozanib Shows Longer PFS Over Bevacizumab In Phase II CRC Trial
Industry Brief - ORYX Completes Phase I/IIa Trial Of MicOryx In MSI-H Colorectal Cancer
Industry Brief - DelMar Granted US Patent NoA Covering VAL-083
Industry Brief - Heidelberg Secures EU Grant To Develop Tumour-Specific Peptide-Drug Conjugates
Industry Trend Analysis - Roche Most At Risk From Upcoming Biosimilar Oncology Market
Industry Brief - TG/Checkpoint Enter Collaboration For Novel Immuno-Oncology Targeted Abs
Industry Trend Analysis - Zarxio's Approval Will See Focus Shift To Battle For Market Acceptance
Industry Brief - Aura Raises Funds To Advance Rare Ocular Cancer Therapies Into Clinic
Industry Trend Analysis - AbbVie Makes Surprise Acquisition Of Pharmacyclics

Table Of Contents

Cancer Drug News 09 MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.